- Home
- VPG vs LRMR Comparison
VPG vs LRMR Comparison
Compare VPG & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VPG
- LRMR
- Stock Information
- Founded
- VPG 2009
- LRMR N/A
- Country
- VPG United States
- LRMR United States
- Employees
- VPG N/A
- LRMR N/A
- Industry
- VPG Electrical Products
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- VPG Technology
- LRMR Health Care
- Exchange
- VPG Nasdaq
- LRMR Nasdaq
- Market Cap
- VPG 374.5M
- LRMR 309.8M
- IPO Year
- VPG N/A
- LRMR N/A
- Fundamental
- Price
- VPG $33.20
- LRMR $4.18
- Analyst Decision
- VPG
- LRMR Strong Buy
- Analyst Count
- VPG 0
- LRMR 7
- Target Price
- VPG N/A
- LRMR $18.43
- AVG Volume (30 Days)
- VPG 81.8K
- LRMR 1.3M
- Earning Date
- VPG 11-04-2025
- LRMR 10-29-2025
- Dividend Yield
- VPG N/A
- LRMR N/A
- EPS Growth
- VPG N/A
- LRMR N/A
- EPS
- VPG N/A
- LRMR N/A
- Revenue
- VPG $295,282,000.00
- LRMR N/A
- Revenue This Year
- VPG N/A
- LRMR N/A
- Revenue Next Year
- VPG $5.40
- LRMR N/A
- P/E Ratio
- VPG N/A
- LRMR N/A
- Revenue Growth
- VPG N/A
- LRMR N/A
- 52 Week Low
- VPG $18.57
- LRMR $1.61
- 52 Week High
- VPG $32.99
- LRMR $9.50
- Technical
- Relative Strength Index (RSI)
- VPG 73.02
- LRMR 59.97
- Support Level
- VPG $28.71
- LRMR $3.84
- Resistance Level
- VPG $32.93
- LRMR $4.28
- Average True Range (ATR)
- VPG 1.16
- LRMR 0.26
- MACD
- VPG 0.37
- LRMR 0.01
- Stochastic Oscillator
- VPG 92.93
- LRMR 86.40
About VPG Vishay Precision Group Inc.
Vishay Precision Group Inc manufactures and markets sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates the maximum of its revenue from the United States.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.